Princeton Capital Management LLC Alaunos Therapeutics, Inc. Transaction History

Princeton Capital Management LLC

  • $313 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$1.61 - $3.62 $1,368 - $3,077
-850 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$2.26 - $3.27 $13,559 - $19,620
-6,000 Reduced 87.59%
850 $3,000
Q1 2018

May 03, 2018
BUY
$3.46 - $5.14 $23,701 - $35,209
6,850 New
6,850 $27,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email